GlassScriptPhysician profile
Michael A Howard
NPI 1366542789
$2,528.09
in general payments reported to CMS, 2019-2025
14 companies · $234 in 2025
The $234 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $34.49 · 2021: $26.04 · 2022: $677 · 2023: $432 · 2024: $950 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816 · Honoraria: $550 · Consulting Fee: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $816.44 |
| Honoraria | $550.00 |
| Consulting Fee | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $1,174.62 | 2022-2025 | Arista, Arista Ah Flexitip |
| Avita Medical Americas, LLC | $250.00 | 2024 | |
| Mentor Worldwide LLC | $200.72 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Baxter Healthcare | $171.43 | 2023 | Artiss |
| Abbvie INC. | $168.84 | 2023-2024 | |
| Stryker Corporation | $152.33 | 2022 | |
| Abbott Laboratories | $134.53 | 2023 | Navitor |
| Allergan, INC. | $77.13 | 2019-2022 | |
| Sientra, INC. | $58.26 | 2021-2022 | |
| Mesh Suture INC | $53.97 | 2023 | |
| Motiva USA, LLC | $32.97 | 2025 | |
| Integra Lifesciences Corporation | $27.47 | 2023 | Durasorb Monofilament Mesh |
| Aesculap, INC. | $13.84 | 2025 | Aesculap |
| Smith+Nephew, INC. | $11.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.